Risk factors for low vision related functioning in the Mycotic Ulcer Treatment Trial: a randomised t...
Risk factors for low vision related functioning in the Mycotic Ulcer Treatment Trial: a randomised trial comparing natamycin with voriconazole
About this item
Full title
Author / Creator
Rose-Nussbaumer, Jennifer , Prajna, N Venkatesh , Krishnan, Tiruvengada , Mascarenhas, Jeena , Rajaraman, Revathi , Srinivasan, Muthiah , Raghavan, Anita , Oldenburg, Catherine E , O'Brien, Kieran S , Ray, Kathryn J , Porco, Travis C , McLeod, Stephen D , Acharya, Nisha R , Keenan, Jeremy D , Lietman, Thomas M and Mycotic Ulcer Treatment Trial Group
Publisher
England: BMJ Publishing Group LTD
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group LTD
Subjects
More information
Scope and Contents
Contents
Background/aimsThe Mycotic Ulcer Treatment Trial I (MUTT I) was a double-masked, multicentre, randomised controlled trial, which found that topical natamycin is superior to voriconazole for the treatment of filamentous fungal corneal ulcers. In this study, we determine risk factors for low vision-related quality of life in patients with fungal kera...
Alternative Titles
Full title
Risk factors for low vision related functioning in the Mycotic Ulcer Treatment Trial: a randomised trial comparing natamycin with voriconazole
Authors, Artists and Contributors
Author / Creator
Prajna, N Venkatesh
Krishnan, Tiruvengada
Mascarenhas, Jeena
Rajaraman, Revathi
Srinivasan, Muthiah
Raghavan, Anita
Oldenburg, Catherine E
O'Brien, Kieran S
Ray, Kathryn J
Porco, Travis C
McLeod, Stephen D
Acharya, Nisha R
Keenan, Jeremy D
Lietman, Thomas M
Mycotic Ulcer Treatment Trial Group
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4965324
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4965324
Other Identifiers
ISSN
0007-1161
E-ISSN
1468-2079
DOI
10.1136/bjophthalmol-2015-306828
